GlassScriptPhysician profile
David J Defilippis
NPI 1982605192
$971.73
in general payments reported to CMS, 2019-2025
15 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $31.41 · 2021: $41.81 · 2022: $124 · 2023: $29.89 · 2024: $148 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $532.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $385.31 | 2022-2025 | Tisseel |
| Hologic Sales and Service, LLC | $195.75 | 2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Abbvie INC. | $73.07 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $48.21 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $37.48 | 2019 | |
| Covidien LP | $36.05 | 2019-2020 | |
| Allergan, INC. | $29.57 | 2019 | |
| Medical Device Business Services, INC. | $28.30 | 2021 | |
| Merck Sharp & Dohme LLC | $27.91 | 2019 | |
| Astellas Pharma US INC | $27.01 | 2025 | Veozah |
| Ethicon US, LLC | $22.90 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.89 | 2019 | |
| Exeltis, USA INC. | $13.20 | 2019 | |
| Terumo Medical Corporation | $12.63 | 2019 | |
| Ferring Pharmaceuticals INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Defilippis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.